Life science companies are built upon successful strategic relationships and transactions. The key to a successful transaction is identifying realistic objectives, locating the right partners, structuring a deal that meets the needs of both parties, and managing the negotiations to reach a successful outcome.

TCG can help. With our years of experience and large network of international contacts, we can lead and advise:

  • In-licensing and out-licensing
  • Development/commercialization partnerships
  • Mergers and acquisitions
  • Process-driven asset sales
  • Private equity or debt financing*

*TCG provides these services through its affiliation with Daybreak Capital Partners, a New York-based specialty investment banking firm.

Case Studies

Medical Devices

Developed a turnaround strategy for poorly-performing US subsidiary of a European medical device company

View Case Study

Sourced US distributors and negotiated agreements for European orthopedic products supplier

View Case Study

Pharma & Biotech

Developed US market entry options for a mid-sized public European pharmaceutical company

View Case Study

Leading licensing/partnering activities for an early stage gene therapy company

View Case Study

Other Life Science

In-licensing of European diagnostic products and technologies

View Case Study

Identified US partners for early stage European technologies

View Case Study